At 9.6% CAGR, the Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market is projected to be worth US$ 207.68 million by 2030, says Business Market Insights

According to Business Market Insights research, the Asia Pacific dental bone graft substitute and barrier membrane market was valued at US$ 99.42 million in 2022 and is expected to reach US$ 207.68 million by 2030, registering a CAGR of 9.6% from 2022 to 2030. Increasing burden of periodontal diseases and oral cancer, and strategic developments by market players are the critical factors attributed to the Asia Pacific dental bone graft substitute and barrier membrane market expansion.

Technological developments are making it easier for dentists to do their job quickly, safely, and comfortably. Technologically advanced instruments make dental hygiene appointments much more pleasant for patients than they used to be. As a result, patients become compliant and willingly schedule treatment and recall visits. Restorative dentistry benefits overall oral health (especially effective teeth and oral care) and improve facial appearance. Using new dental implantation techniques, and advanced navigation and monitoring technologies, dentists can insert implants through minimally invasive surgeries. Augmented reality (AR) technology is more prevalent in reconstructive and aesthetic procedures in dental practices, as artificial intelligence (AI) can show patients how they would look after the treatment. Further, the increasing adoption of synthetic bone substitutes is likely to favor the growth of the dental graft substitute and barrier membrane market. In 2020, Orthopediatrics Corp., a company focused solely on pediatric orthopedics, launched QuickPack, an all-synthetic replacement containing a high-viscosity calcium phosphate cement that mimics the mineral phase of natural bone. In July 2020, Spine Wave Inc. announced the launch of the Temptest allograft bone matrix that comprises cancellous and partially demineralized cortical bone. Thus, such technologically advanced dental membranes and bone grafts are expected to provide growth opportunities for the market players in the coming years.

On the contrary, high cost of products & procedures and delays in dental check-ups hampers the Asia Pacific dental bone graft substitute and barrier membrane market.  

Based on product, the Asia Pacific dental bone graft substitute and barrier membrane market has been bifurcated into dental bone graft substitutes and dental barrier membranes. The dental bone graft substitutes segment held 75.7% share of Asia Pacific dental bone graft substitute and barrier membrane market in 2022, amassing US$ 75.31 million. It is projected to garner US$ 154.99 million by 2030 to expand at 9.4% CAGR during 2022–2030. 

Based on procedures, the Asia Pacific dental bone graft substitute and barrier membrane market is segmented into guided bone regeneration (GBR) procedures, guided tissue regeneration (GTR) procedures, sinus-lift and ridge-split procedures, alveolar ridge preservation (ARP), block-graft procedures, periodontal regeneration procedures, socket preservation, and others. The sinus-lift and ridge-split procedures segment held 23.3% share of Asia Pacific dental bone graft substitute and barrier membrane market in 2022, amassing US$ 23.14 million. It is projected to garner US$ 47.76 million by 2030 to expand at 9.5% CAGR during 2022–2030.

Based on end user, the Asia Pacific dental bone graft substitute and barrier membrane market is segmented into hospitals, dental clinics, and others. The dental clinics procedures segment held 75.7% share of Asia Pacific dental bone graft substitute and barrier membrane market in 2022, amassing US$ 70.32 million. It is projected to garner US$ 152.09 million by 2030 to expand at 10.1% CAGR during 2022–2030.

Based on country, the Asia Pacific dental bone graft substitute and barrier membrane market has been categorized into the China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 29.3% share of Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market in 2022. It was assessed at US$ 29.08 million in 2022 and is likely to hit US$ 59.91 million by 2030, exhibiting a CAGR of 9.5% during the 2022-2030.      

Key players operating in the Asia Pacific dental bone graft substitute and barrier membrane Market are Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, ZimVie Inc, Regenity Biosciences Inc, Neoss UK & Ireland Ltd, and Institut Straumann AG, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com